DexCom Expands CGM Access in Germany With New Dexcom Flex System for Type 2 Diabetes
MT Newswires Live
May 18
DexCom (DXCM) said Monday that it launched Dexcom Flex, a continuous glucose monitoring (CGM) system for adults with Type 2 diabetes who are not using intensive insulin therapy, in Germany.
The system is aimed at patients using basal insulin, oral medications or GLP-1 drugs and provides real-time glucose readings through smartphones or smartwatches without routine fingerpricks, DexCom said.
DexCom said the device includes customizable low-glucose alerts and tracking tools for food and activity. The company cited studies showing CGM use in Type 2 diabetes patients may help lower HbA1c levels and reduce diabetes-related complications and hospitalizations.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.